Eculizumab biosimilar Elizaria demonstrates long-term safety and efficacy comparable with the reference product Soliris in ...

A college student gets over the flu, but two weeks later feels winded after climbing stairs and complains of abdominal pain.

PNH is a blood disorder where mutated hematopoietic stem cells produce red blood cells that are prone to destruction by the complement system. It affects approximately 10-20 individuals per ...

A novel drug combination, improvements in quality of life, and breakthrough hemolysis control are among the clinical highlights in paroxysmal nocturnal hemoglobinuria (PNH) presented at the 2024 ...

which showed that crovalimab was as effective as Soliris at controlling the destruction of red blood cells (haemolysis) that characterises PNH, whilst also reducing the need for blood transfusions.

which showed that the drug was equivalent to Soliris at controlling the destruction of red blood cells (haemolysis) that characterises PNH, whilst also reducing the need for blood transfusions.